Microbiota Intervention to Change the Response of Parkinson's Disease

NCT03575195 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

86

Enrollment

OTHER

Sponsor class

Stopped Conducting an interim analysis

Conditions

Parkinson Disease

Interventions

DRUG: Rifaximin
OTHER: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]